Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,250,000 | 1,225,000 | 270,123 | 372,152 | 208,130 |
| Marketable Securities | 1,243,000 | 1,140,000 | 1,394,982 | 1,139,620 | 826,442 |
| Receivables | 1,666,000 | 1,050,000 | 959,955 | 597,397 | 418,481 |
| Inventories | 1,178,000 | 703,000 | 590,343 | 469,640 | 393,542 |
| Income taxes - deferred | 278,000 | 167,000 | 148,370 | 121,885 | 82,299 |
| Other current assets | 0 | 0 | 0 | 0 | 103,148 |
| TOTAL | $5,704,000 | $4,386,000 | $3,425,340 | $2,780,136 | $2,082,784 |
| Non-Current Assets | |||||
| PPE Net | 4,173,000 | 3,349,000 | 2,091,404 | 1,617,912 | 1,068,734 |
| Investments And Advances | 1,832,000 | 1,449,000 | 1,115,327 | 1,422,886 | 567,286 |
| Intangibles | 1,791,000 | 1,889,000 | 1,983,410 | 2,125,829 | 2,242,557 |
| Other Non-Current Assets | 1,342,000 | 1,074,000 | 787,914 | 812,714 | 796,758 |
| TOTAL | $9,138,000 | $7,761,000 | $5,978,055 | $5,979,341 | $4,675,335 |
| Total Assets | $14,842,000 | $12,147,000 | $9,403,395 | $8,759,477 | $6,758,119 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 346,000 | 339,000 | 104,832 | 59,700 | 51,380 |
| TOTAL | $2,010,000 | $1,660,000 | $1,238,030 | $896,337 | $646,660 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,204,000 | 2,083,000 | 412,250 | 412,250 | N/A |
| Deferred Revenues | 62,000 | 44,000 | 45,989 | 47,478 | 20,044 |
| Other Non-Current Liabilities | 951,000 | 714,000 | 703,120 | 649,349 | 554,728 |
| TOTAL | $3,354,000 | $3,017,000 | $1,383,175 | $1,342,842 | $772,575 |
| Total Liabilities | $5,364,000 | $4,677,000 | $2,621,205 | $2,239,179 | $1,419,235 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,053,186 | 1,053,872 | 1,046,300 | 1,054,058 | 1,025,156 |
| Common Shares | 21,000 | 21,000 | 20,943 | 20,990 | 10,256 |
| Retained earnings | -838,000 | -2,067,000 | -1,532,455 | -1,157,141 | -1,590,366 |
| Other shareholders' equity | 204,000 | 253,000 | 290,948 | 297,033 | 268,642 |
| TOTAL | $9,478,000 | $7,470,000 | $6,782,190 | $6,520,298 | $5,338,884 |
| Total Liabilities And Equity | $14,842,000 | $12,147,000 | $9,403,395 | $8,759,477 | $6,758,119 |